SERPINE1 and metabolic syndrome: Nevertheless, this randomized trial provides high-level evidence of the benefits of an intervention with a restrictive MedDiet and physical activity, especially on weight, waist circumference, leptin levels, lipid/glucose metabolism, blood pressure, and the pro-inflammatory marker PAI-1 at mid-and long-term intervention in subjects with metabolic syndrome.